Sally Oliver
Adult Health · Sebring, FLNPI 1164894317
Payments from drug & device makers
Across 182 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$471
- AstraZeneca$318
- Novo Nordisk$269
- Pfizer$246
- Otsuka America Pharmaceutical, Inc.$217
- Novartis$199
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,24299%
- Education$281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $471 |
| AstraZeneca | 21 | $318 |
| Novo Nordisk | 16 | $269 |
| Pfizer | 12 | $246 |
| Otsuka America Pharmaceutical, Inc. | 10 | $217 |
| Novartis | 11 | $199 |
| Bayer | 8 | $165 |
| Merck | 8 | $164 |
| Antares Pharma, Inc. | 8 | $136 |
| Amgen | 8 | $128 |
| Exact Sciences | 6 | $106 |
| Esperion Therapeutics, Inc. | 4 | $73 |
| Boehringer Ingelheim | 4 | $71 |
| Corcept Therapeutics | 4 | $70 |
| Halozyme Inc | 4 | $66 |
| Boston Scientific | 4 | $63 |
| Sanofi-aventis U.S. LLC | 3 | $59 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $56 |
| Lilly USA, LLC | 3 | $55 |
| GSK | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Radius Health, Inc. | 2 | $38 |
| Johnson & Johnson | 2 | $32 |
| Eisai Inc. | 1 | $32 |
| Dexcom, Inc. | 1 | $25 |
| Bausch Health US, LLC | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Averitas Pharma Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $14 |
| Electromed, Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
How this compares
$3,270 in reported general payments places this provider in the 85th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 48 | $69,429 |
| MounjaroTirzepatide | 46 | $59,965 |
| OzempicSemaglutide | 28 | $39,287 |
| FarxigaDapagliflozin Propanediol | 35 | $38,375 |
| JardianceEmpagliflozin | 22 | $22,925 |
| LinzessLinaclotide | 11 | $13,748 |
| ViberziEluxadoline | 12 | $8,636 |
| Praluent PenAlirocumab | 11 | $6,812 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $4,913 |
| SynthroidLevothyroxine Sodium | 38 | $3,710 |
| Atorvastatin Calcium | 386 | $3,395 |
| Omeprazole | 148 | $2,836 |
| Levothyroxine Sodium | 365 | $2,826 |
| PaxlovidNirmatrelvir/Ritonavir | 13 | $2,821 |
| Gabapentin | 152 | $2,671 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $246 | $72,25061 claims |
| Lilly USA, LLCMounjaro | $55 | $59,96546 claims |
| Novo NordiskOzempic | $269 | $39,28728 claims |
| AstraZenecaFarxiga | $318 | $38,37535 claims |
| AbbVieLinzess, Viberzi, Synthroid | $471 | $26,09461 claims |
| Boehringer IngelheimJardiance | $71 | $22,92522 claims |
| Teva Pharmaceuticals USA, Inc.Acyclovir | $38 | $81525 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,237 adult health providers in Florida.
Other adult health in Sebring
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
- Cynthia OteroMaitland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.